Loading
Latest filing published 22 Jan 2026 for RenovoRx, Inc., €8,505.
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Ramtin Agah is a declared insider of RenovoRx, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 18 filings; the first trade dates from 30 August 2021 and the latest from 21 January 2026.
Every open-market trade on record is a purchase: 14 purchases worth €151k, and no sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 3 purchases and no sales.
The median purchase comes to €8,677. 7 out of 14 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 22 January 2026 with an open-market purchase (€8,505) in RenovoRx, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations